Recent Updates
Recently added Catalysts
RVMD Positive Sentiment Score: 75/100

Revolution Medicines to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Wednesday, January 29, 2025 1 min read
Key Takeaway: Revolution Medicines, Inc. announced that its CEO Mark A. Goldsmith will participate in a fireside chat at the Guggenheim Securities SMID Cap Biotech Conference on February 5, 2025. The conference aims to showcase insights into their development of targeted therapies for RAS-addicted cancers. A live webcast of the event will be available along with a replay for 14 days post-conference.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a significant biotech conference boosts visibility.
  • Engagement with investors and media through the fireside chat.
  • Opportunity to discuss advancements in RAS-addicted cancer therapies.

Full Press Release Details

REDWOOD CITY, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairman, will participate in a fireside chat as part of the Guggenheim Securities SMID Cap Biotech Conference on Wednesday, February 5, 2025, at 10:30 a.m. ET.
To access the live webcast of the presentation, please visit the “Events & Presentations” page of Revolution Medicines’ website at https://ir.revmed.com/events-and-presentations. Additionally, a replay of the webcast will be available on the “Events & Presentations” page of the Revolution Medicines website for at least 14 days following the conference.
About Revolution Medicines, Inc.
Revolution Medicines Media & Investor Contact:
investors@revmed.com

Tags

Frequently Asked Questions

When is Revolution Medicines' fireside chat?

The fireside chat is scheduled for February 5, 2025, at 10:30 a.m. ET.

Who will participate in the fireside chat?

Mark A. Goldsmith, M.D., Ph.D., will participate in the chat.

How can I watch the live webcast?

Visit the “Events & Presentations” page on Revolution Medicines' website.

Will the webcast replay be available?

Yes, a replay will be available for at least 14 days after the conference.

What does Revolution Medicines focus on?

The company develops novel targeted therapies for RAS-addicted cancers.

Tags: RVMD Viatris Investor Conferences Healthcare Revolution Medicines Guggenheim Securities SMID Cap biotech conference
Last updated: Jan 29, 2025